Trial Profile
A Randomized, Double-blind, Parallel Group, Single-Centre Study to Evaluate the Efficacy and Safety of Lacidipine and Amlodipine Once-daily Treatment in Hypertensive Adult Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Lacidipine (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors GSK
- 08 Oct 2006 New trial record.